Study of the Safety and Efficacy of ATS907 in Subjects With Primary Open Angle Glaucoma (POAG) and Ocular Hypertension

NCT01520116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Open Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Stage 1 - ATS907 - Dose 1
DRUG: Stage 1 - ATS907 - Dose 2
DRUG: Stage 1 - ATS907 - Dose 3
DRUG: Stage 1 - ATS907 - Dose 4
DRUG: Stage 1 - Vehicle
DRUG: Stage 2 - ATS907 - Dose A - to be selected based on Stage 1
DRUG: Stage 2 - ATS907 - Dose B - to be selected based on Stage 1
DRUG: Timoptic

Sponsor

Altheos, Inc.